Create Free Account

By creating account you will get access to hot stocks & personalised emails

GE HealthCare Technologies Inc.

Healthcare US GEHC

77.71USD
0.62(0.80%)

Last update at 2024-12-19T18:51:00Z

Day Range

76.9578.18
LowHigh

52 Week Range

62.3094.47
LowHigh

Fundamentals

  • Previous Close 77.09
  • Market Cap35969.44M
  • Volume1471403
  • P/E Ratio22.91
  • Dividend Yield0.15%
  • EBITDA3519.00M
  • Revenue TTM19495.00M
  • Revenue Per Share TTM42.80
  • Gross Profit TTM 7179.00M
  • Diluted EPS TTM3.44

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax 2512.00M 2875.00M 2710.00M 2091.00M
Minority interest -51.00000M -46.00000M -51.00000M -29.00000M
Net income 1916.00M 2247.00M 2058.00M 1524.00M
Selling general administrative 3631.00M 3563.00M 3237.00M 3591.00M
Selling and marketing expenses - - - -
Gross profit 7179.00M 7174.00M 6767.00M 6548.00M
Reconciled depreciation 633.00M 625.00M 630.00M 659.00M
Ebit 2522.00M 2795.00M 2720.00M 2124.00M
Ebitda 3222.00M 3540.00M 3406.00M 2838.00M
Depreciation and amortization 700.00M 745.00M 686.00M 714.00M
Non operating income net other - - - -
Operating income 2522.00M 2795.00M 2720.00M 2124.00M
Other operating expenses 15819.00M 14790.00M 14444.00M 14509.00M
Interest expense 77.00M 40.00M 66.00M 88.00M
Tax provision 563.00M 600.00M 652.00M 410.00M
Interest income - 34.00M 49.00M 36.00M
Net interest income -77.00000M -6.00000M -17.00000M -52.00000M
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense 563.00M 600.00M 652.00M 410.00M
Total revenue 18341.00M 17585.00M 17164.00M 16633.00M
Total operating expenses 4657.00M 4379.00M 4047.00M 4424.00M
Cost of revenue 11162.00M 10411.00M 10397.00M 10085.00M
Total other income expense net -10.00000M 80.00M -10.00000M -33.00000M
Discontinued operations 18.00M 18.00M 11839.00M -128.00000M
Net income from continuing ops 1949.00M 2275.00M 2058.00M 1681.00M
Net income applicable to common shares 1916.00M 2247.00M 13846.00M 1524.00M
Preferred stock and other adjustments - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 32454.00M 27539.00M 26308.00M 24228.00M -
Intangible assets 1253.00M 1520.00M 1847.00M 1603.00M -
Earning assets - - - - -
Other current assets 61.00M 417.00M 88.00M 98.00M -
Total liab 25144.00M 18177.00M 9632.00M 9477.00M -
Total stockholder equity 7133.00M 9357.00M 16655.00M 14727.00M -
Deferred long term liab - 82.00M 77.00M 71.00M -
Other current liab 3000.00M 2336.00M 2247.00M 2417.00M -
Common stock 5.00M 11235.00M 17692.00M 15566.00M -
Capital stock 5.00M 0.00000M 17692.00M 15566.00M -
Retained earnings 1326.00M - - - -
Other liab - 2240.00M 2324.00M 2699.00M -
Good will 12936.00M 12813.00M 12892.00M 11868.00M -
Other assets 3302.00M 2534.00M 1993.00M 2315.00M -
Cash 2494.00M 1445.00M 554.00M 994.00M -
Cash and equivalents - - - - -
Total current liabilities 8981.00M 7191.00M 6761.00M 6524.00M -
Current deferred revenue 1918.00M 1896.00M 1864.00M 1813.00M -
Net debt 7369.00M 6804.00M -117.00000M -526.00000M -
Short term debt 1116.00M 15.00M 110.00M 132.00M -
Short long term debt 1006.00M 15.00M 6.00M 4.00M -
Short long term debt total 9863.00M 8249.00M 437.00M 468.00M -
Other stockholder equity 6493.00M 18801.00M -1037.00000M -839.00000M -
Property plant equipment - 2314.00M 2235.00M 2202.00M -
Total current assets 9410.00M 8318.00M 7000.00M 5896.00M -
Long term investments 357.00M 322.00M 341.00M 344.00M -
Net tangible assets - -4976.00000M 1916.00M 1256.00M -
Short term investments - - - - -
Net receivables 4254.00M 4301.00M 3791.00M 2657.00M -
Long term debt 8436.00M 8234.00M 31.00M 31.00M -
Inventory 1960.00M 2155.00M 1946.00M 1594.00M -
Accounts payable 2947.00M 2944.00M 2540.00M 2162.00M -
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -691.00000M -1878.00000M -1037.00000M -839.00000M -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 1524.00M 702.00M 286.00M 375.00M -
Deferred long term asset charges - - - - -
Non current assets total 23044.00M 19221.00M 19308.00M 18332.00M -
Capital lease obligations 421.00M 386.00M 400.00M 433.00M -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -398.00000M -1761.00000M 19986.00M -325.00000M
Change to liabilities 619.00M 242.00M 199.00M -48.00000M
Total cashflows from investing activities -398.00000M -1761.00000M -323.00000M -325.00000M
Net borrowings 8204.00M -12.00000M -16.00000M -59.00000M
Total cash from financing activities -822.00000M -263.00000M -21544.00000M -1574.00000M
Change to operating activities -81.00000M 251.00M 9.00M 84.00M
Net income 1949.00M 2275.00M 2058.00M 1681.00M
Change in cash 890.00M -451.00000M 143.00M 35.00M
Begin period cash flow 561.00M 1012.00M 869.00M 834.00M
End period cash flow 1451.00M 561.00M 1012.00M 869.00M
Total cash from operating activities 2113.00M 1607.00M 1687.00M 1989.00M
Issuance of capital stock - - - -
Depreciation 633.00M 625.00M 630.00M 659.00M
Other cashflows from investing activities -92.00000M -47.00000M -2.00000M -46.00000M
Dividends paid - - - -
Change to inventory -402.00000M -435.00000M 100.00M -173.00000M
Change to account receivables -231.00000M -1336.00000M -221.00000M -272.00000M
Sale purchase of stock - - - -
Other cashflows from financing activities -819.00000M -246.00000M -21524.00000M -1511.00000M
Change to netincome -341.00000M 13.00M -12876.00000M 215.00M
Capital expenditures 310.00M 248.00M 259.00M 331.00M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital -256.00000M -1370.00000M -52.00000M -387.00000M
Stock based compensation - - -931.00000M 151.00M
Other non cash items -776.00000M -523.00000M -670.00000M -525.00000M
Free cash flow 1803.00M 1359.00M 1428.00M 1658.00M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
GEHC
GE HealthCare Technologies Inc.		 0.62 0.80% 77.71 22.91 20.12 2.01 5.52 2.39 13.30
VEEV
Veeva Systems Inc Class A		 -2.02 0.91% 219.52 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc		 - -% 9.73 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc		 -0.13 2.97% 4.25 31.84 26.25 0.05 4.60 0.04 0.12
HQY
HealthEquity Inc		 3.08 3.36% 94.62 123.86 42.37 6.88 3.38 7.41 26.13

Reports Covered

Stock Research & News

View All

Profile

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

GE HealthCare Technologies Inc.

500 West Monroe Street, Chicago, IL, United States, 60661

Key Executives

Name Title Year Born
Mr. Peter J. Arduini President, CEO & Director 1965
Mr. James K. Saccaro VP & CFO 1973
Dr. Taha Kass-Hout M.D., M.S. Chief Science & Technology Officer 1972
Mr. Frank R. Jimenez Esq. VP, General Counsel & Corporate Secretary 1965
Mr. Jan Makela President & CEO of Imaging 1969
Mr. George Andrew Newcomb Controller & Chief Accounting Officer 1967
Mr. Jahid Khandaker Chief Information Officer NA
Ms. Carolynne Borders Chief Investor Relations Officer NA
Ms. Rana Strellis Chief Corporate Marketing & Communications Officer NA
Mr. Thomas J. Westrick President & CEO of Patient Care Solutions 1969

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.